Transcranial Magnetic Stimulation Optimized for Research
Brainsway® Deep Transcranial Magnetic Stimulation device includes a double blinding system for easily conducting randomized studies. Our Transcranial Magnetic Stimulation system features smart cards which are randomized between the patients. At the beginning of each treatment, the patient’s individual smart card is inserted into the card reader, automatically activating either the real coil or the sham coil, which are both located in the patient's head set. Both coils produce similar scalp sensations and acoustic artifact, so that neither the patient nor the caregiver knows whether the treatment taking place is real or sham.
Applicable for a Variety of Clinical & Neuroscience Studies
Brainsway Transcranial Magnetic Stimulation device can stimulate a wide variety of brain regions and networks. The Transcranial Magnetic Stimulation treatment can easily be applied to diverse clinical applications by designing coils targeting different locations, depths, directionalities & morphologies relevant to target neuronal structures, and usage of different protocols during treatment.
Brain regions which have been stimulated in various studies using Brainsway Transcranial Magnetic Stimulation device include:
Lateral and medial prefrontal cortex (PFCׁׁ)
Right & left Insular cortex and entorhinal cortex
Anterior cingulate cortex
Posterior cingulate cortex
Lateral and medial motor cortex, including deeper leg motor cortex
Supplementary motor cortex
Right and left temporal cortex structures, including fusiform face area (FFA) & superior temporal sulcus (STS)
Parietal cortex regions
Occipital cortex regions
Deep Stimulation – High Efficacy
Studies have shown that the depth and wide range of brain stimulation significantly and positively impact the results.
“Many behavioral manifestations of neurological and psychiatric diseases are not solely the result of abnormality in one isolated brain region but represent alterations in brain networks and connectivity.” (Fox et al. Neurolmage 2012)
"Deeper (ventral) PFC structures have significantly more connections with other reward system sites compared to superficial PFC". (Leh et al., 2007)
Brainsway’s H-coil stimulation is deeper than that of Surface TMS coil. Therefore, it can stimulate tissues that have higher connectivity to the reward system.
“There is significant inter-individual variability in the exact location of DLPFC sites having functional connectivity with subgenual cingulate “(Fox et al. Neuroimage 2012)
“Effective response to standard TMS in MDD is strongly correlated with resting state functional connectivity between DLPFC stimulation sites and subgenual cingulate “(Fox et al. Biol. Psychiatry 2012)
“Individualized targeting becomes less important with larger stimulation field sizes” (Fox et al. Biol. Psychiatry 2012)
Brainsway's international website includes clinical and regulatory data for indications which were not cleared by the FDA for use in the United States.
This site is not intended for residents of the United States, its territories, and Puerto Rico.
The FDA cleared Brainsway's Deep TMS system for use in the U.S for treatment of depressive episodes in adult patients suffering from Major Depressive Disorder who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode.
Would you like to proceed to the international website? To proceed click here
or click here to close this window